Commerce Bank Acquires New Shares in Axon Enterprise, Inc $AXON

Posted by Brian Himes on Aug 25th, 2026

Commerce Bank acquired a new position in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) in the 2nd quarter, Holdings Channel reports. The firm acquired 4,596 shares of the biotechnology company’s stock, valued at approximately $2,577,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Creative Financial Designs Inc. ADV purchased a new stake in Axon Enterprise in the fourth quarter valued at $28,000. Camelot Portfolios LLC purchased a new position in shares of Axon Enterprise during the 4th quarter worth $30,000. Keating Financial Advisory Services Inc. acquired a new stake in shares of Axon Enterprise during the 2nd quarter worth about $31,000. AlphaCentric Advisors LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter worth about $34,000. Finally, Darwin Wealth Management LLC purchased a new stake in Axon Enterprise in the 2nd quarter valued at about $37,000. Institutional investors and hedge funds own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on AXON. Needham & Company LLC reaffirmed a “buy” rating on shares of Axon Enterprise in a research report on Thursday, August 6th. Royal Bank Of Canada reiterated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, July 21st. The Goldman Sachs Group reissued a “buy” rating and issued a $715.00 price target on shares of Axon Enterprise in a research note on Thursday, August 6th. Citizens Jmp restated a “market outperform” rating and issued a $700.00 price objective on shares of Axon Enterprise in a report on Thursday, June 25th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axon Enterprise in a research report on Wednesday, August 5th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $730.92.

View Our Latest Report on AXON

Axon Enterprise Price Performance

AXON stock opened at $597.59 on Tuesday. The business’s fifty day moving average price is $546.20 and its 200 day moving average price is $478.02. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $794.29. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. The company has a market capitalization of $48.55 billion, a PE ratio of 247.96, a P/E/G ratio of 10.19 and a beta of 1.39.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.84 by $0.04. The company had revenue of $904.39 million during the quarter, compared to analysts’ expectations of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.Axon Enterprise’s revenue for the quarter was up 35.3% on a year-over-year basis. During the same period last year, the business posted $2.12 EPS. On average, sell-side analysts anticipate that Axon Enterprise, Inc will post 2.04 EPS for the current year.

Insider Buying and Selling at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 9,605 shares of the stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the sale, the insider owned 97,761 shares of the company’s stock, valued at approximately $61,266,818.70. This represents a 8.95% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CRO Cameron Brooks sold 1,242 shares of the firm’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $500.00, for a total transaction of $621,000.00. Following the completion of the transaction, the executive directly owned 49,710 shares of the company’s stock, valued at approximately $24,855,000. The trade was a 2.44% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders have sold 76,594 shares of company stock valued at $41,236,386. Corporate insiders own 4.20% of the company’s stock.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.